VLAD DRAGALIN Vice President, Scientific Fellow at Janssen, Pharmaceutical Companies of Johnson and Johnson
Adaptive designs expert with 25 years experience in developing the statistical methodology of adaptive designs, with over 12 years experience in pharmaceutical industry including positions at GlaxoSmithKline, Wyeth, Pfizer and at leading CROs Quintiles and Aptiv Solutions.
Fellow of the American Statistical Association and Member of the Drug Information Association, the Society for Clinical Trials, the International Society for CNS Clinical Trials and Methodology, and an Associate Editor of Journal of Biopharmaceutical Statistics. Actively involved in the PhRMA Working Group on Adaptive Designs and the PhRMA Working Group on Adaptive Dose Ranging Studies (currently under DIA) and an elected member of the PhRMA Biostatistics and Data Management Technical Group.
- 127 vizualizări